Name | Number of supported studies | Average coverage | |
---|---|---|---|
paneth cell | 3 studies | 97% ± 2% | |
acinar cell | 3 studies | 65% ± 27% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 3 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 221957.04 | 328 / 328 | 53% | 1296.45 | 95 / 178 |
stomach | 79% | 3429.26 | 283 / 359 | 33% | 361.04 | 94 / 286 |
intestine | 46% | 15702.08 | 441 / 966 | 37% | 267.03 | 197 / 527 |
adrenal gland | 77% | 246.18 | 198 / 258 | 1% | 1.15 | 3 / 230 |
liver | 33% | 21.48 | 75 / 226 | 20% | 472.91 | 82 / 406 |
esophagus | 26% | 34.55 | 380 / 1445 | 17% | 106.81 | 31 / 183 |
spleen | 41% | 28.01 | 100 / 241 | 0% | 0 | 0 / 0 |
ovary | 33% | 18.99 | 59 / 180 | 0% | 0 | 0 / 430 |
prostate | 31% | 10.30 | 75 / 245 | 0% | 0 | 0 / 502 |
uterus | 25% | 13.43 | 43 / 170 | 0% | 36.86 | 2 / 459 |
lung | 20% | 15.28 | 118 / 578 | 5% | 20.37 | 54 / 1155 |
kidney | 22% | 8.19 | 20 / 89 | 0% | 0.04 | 1 / 901 |
thymus | 22% | 16.75 | 141 / 653 | 0% | 0 | 0 / 605 |
breast | 21% | 16.32 | 97 / 459 | 0% | 0 | 0 / 1118 |
adipose | 20% | 296.59 | 241 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 19% | 14.35 | 247 / 1335 | 0% | 0 | 0 / 0 |
bladder | 10% | 1.86 | 2 / 21 | 9% | 107.11 | 45 / 504 |
heart | 17% | 17.22 | 150 / 861 | 0% | 0 | 0 / 0 |
skin | 16% | 8.19 | 297 / 1809 | 0% | 0.15 | 1 / 472 |
brain | 15% | 22.62 | 404 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 13% | 9.40 | 120 / 929 | 0% | 0 | 0 / 0 |
muscle | 12% | 6.79 | 100 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006953 | Biological process | acute-phase response |
GO_0043434 | Biological process | response to peptide hormone |
GO_0007165 | Biological process | signal transduction |
GO_0010838 | Biological process | positive regulation of keratinocyte proliferation |
GO_0009609 | Biological process | response to symbiotic bacterium |
GO_0045617 | Biological process | negative regulation of keratinocyte differentiation |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0106015 | Biological process | negative regulation of inflammatory response to wounding |
GO_2000972 | Biological process | positive regulation of detection of glucose |
GO_0009611 | Biological process | response to wounding |
GO_0007157 | Biological process | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0005179 | Molecular function | hormone activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0070492 | Molecular function | oligosaccharide binding |
GO_0005515 | Molecular function | protein binding |
Gene name | REG3A |
Protein name | Regenerating family member 3 alpha Alternative protein REG3A Regenerating islet-derived protein 3-alpha (REG-3-alpha) (Hepatointestinal pancreatic protein) (HIP/PAP) (Human proislet peptide) (HIP) (Pancreatitis-associated protein 1) (Regenerating islet-derived protein III-alpha) (Reg III-alpha) [Cleaved into: Regenerating islet-derived protein 3-alpha 16.5 kDa form; Regenerating islet-derived protein 3-alpha 15 kDa form] Proliferation-inducing protein 34 (Proliferation-inducing protein 42) (Regenerating islet-derived 3 alpha, isoform CRA_a) (cDNA FLJ76569, highly similar to Homo sapiens regenerating islet-derived 3 alpha (REG3A), transcript variant 1, mRNA) |
Synonyms | hCG_39519 PAP HIP PAP1 |
Description | FUNCTION: [Regenerating islet-derived protein 3-alpha 15 kDa form]: Bactericidal C-type lectin which acts exclusively against Gram-positive bacteria and mediates bacterial killing by binding to surface-exposed carbohydrate moieties of peptidoglycan . Binds membrane phospholipids and kills bacteria by forming a hexameric membrane-permeabilizing oligomeric pore . .; FUNCTION: Acts as a hormone in response to different stimuli like anti-inflammatory signals, such as IL17A, or gut microbiome. Secreted by different cell types to activate its receptor EXTL3 and induce cell specific signaling pathways . Induced by IL17A in keratinocytes, regulates keratinocyte proliferation and differentiation after skin injury via activation of EXTL3-PI3K-AKT signaling pathway . In parallel, inhibits skin inflammation through the inhibition of inflammatory cytokines such as IL6 and TNF . In pancreas, is able to permealize beta-cells membrane and stimulate their proliferation . .; FUNCTION: [Regenerating islet-derived protein 3-alpha 16.5 kDa form]: Has bacteriostatic activity. . |
Accessions | A0A669KAZ1 ENST00000393878.5 Q06141 ENST00000305165.3 ENST00000490901.2 ENST00000409839.7 Q53S56 L8E7R5 |